| 前收盘价格 | 20.06 |
| 收盘价格 | 20.20 |
| 成交量 | 522,970 |
| 平均成交量 (3个月) | 677,127 |
| 市值 | 1,087,323,008 |
| 预期市盈率 (P/E Forward) | 94.34 |
| 价格/销量 (P/S) | 2.65 |
| 股市价格/股市净资产 (P/B) | 3.41 |
| 52周波幅 | |
| 利润日期 | 28 Apr 2026 |
| 营业毛利率 | 17.92% |
| 营业利益率 (TTM) | -9.46% |
| 稀释每股收益 (EPS TTM) | 1.12 |
| 季度收入增长率 (YOY) | 17.50% |
| 总债务/股东权益 (D/E MRQ) | 7.98% |
| 流动比率 (MRQ) | 4.11 |
| 营业现金流 (OCF TTM) | 26.78 M |
| 杠杆自由现金流 (LFCF TTM) | 29.89 M |
| 资产报酬率 (ROA TTM) | -5.20% |
| 股东权益报酬率 (ROE TTM) | 19.54% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 看涨 |
| Diagnostics & Research (全球的) | 混合的 | 看涨 | |
| 股票 | CareDx, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 1.5 |
| 内部交易活动 | 3.0 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.60 |
|
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Core |
| 内部持股比例 | 3.22% |
| 机构持股比例 | 99.39% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 26.00 (BTIG, 22.47%) | 购买 |
| 中 | 23.50 (10.69%) | |
| 低 | 21.00 (Wells Fargo, -1.08%) | 保留 |
| 平均值 | 23.50 (10.69%) | |
| 总计 | 1 购买, 1 保留 | |
| 平均价格@调整类型 | 18.64 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 26 Feb 2026 | 26.00 (22.47%) | 购买 | 18.82 |
| Wells Fargo | 25 Feb 2026 | 21.00 (-1.08%) | 保留 | 18.46 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| KENNEDY KEITH | 21.29 | - | 24,134 | 513,813 |
| 累积净数量 | 24,134 | |||
| 累积净值 ($) | 513,813 | |||
| 累积平均购买 ($) | 21.29 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| KENNEDY KEITH | 职员 | 20 Apr 2026 | 获得 (+) | 24,134 | 21.29 | 513,813 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合